Hsbc Holdings PLC Biomarin Pharmaceutical Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 200,395 shares of BMRN stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

200,395

Previous 89,795 123.17%

Holding current value

$13.3 Million

Previous $7.39 Million 90.54%

% of portfolio

0.01%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $7.63 Million - $10.4 Million	110,600 Added 123.17%	200,395 $14.1 Million
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $10.6 Million - $13.2 Million	-142,903 Reduced 61.41%	89,795 $7.39 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $16.5 Million - $19.4 Million	-196,359 Reduced 45.77%	232,698 $20.3 Million
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $13.6 Million - $17.5 Million	-178,041 Reduced 29.33%	429,057 $41.4 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $36.9 Million - $41 Million	434,199 Added 251.13%	607,098 $53.7 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $1.64 Million - $1.89 Million	-18,888 Reduced 9.85%	172,899 $15 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $9.19 Million - $12.3 Million	-104,788 Reduced 35.33%	191,787 $18.6 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $15.8 Million - $21.2 Million	195,495 Added 193.41%	296,575 $30.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.69 Million - $4.36 Million	44,955 Added 80.1%	101,080 $8.62 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $2.01 Million - $2.44 Million	-28,150 Reduced 33.4%	56,125 $4.68 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $2.58 Million - $3.22 Million	34,713 Added 70.04%	84,275 $6.53 Million
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $2.53 Million - $3.23 Million	-35,335 Reduced 41.62%	49,562 $4.38 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $2.32 Million - $2.65 Million	31,007 Added 57.54%	84,897 $6.56 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $842,691 - $946,256	11,160 Added 26.12%	53,890 $4.5 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $409,370 - $496,799	-5,478 Reduced 11.36%	42,730 $3.23 Million
Q4 2020 Feb 25, 2021	BUY	$72.61 - $90.2 $1.26 Million - $1.56 Million	17,343 Added 56.19%	48,208 $4.23 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $2.82 Million - $3.51 Million	-38,878 Reduced 55.74%	30,865 $2.71 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $2.01 Million - $3.66 Million	27,931 Added 66.8%	69,743 $5.33 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $933,837 - $1.46 Million	-11,739 Reduced 21.92%	41,812 $5.16 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $1.45 Million - $1.96 Million	20,266 Added 60.89%	53,551 $4.49 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $532,476 - $715,575	-8,285 Reduced 19.93%	33,285 $2.82 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $1.04 Million - $1.32 Million	15,493 Added 59.41%	41,570 $2.8 Million
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $892,447 - $1.04 Million	-11,107 Reduced 29.87%	26,077 $2.23 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $20.1 Million - $23.5 Million	-238,585 Reduced 86.52%	37,184 $3.3 Million
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $4.41 Million - $5.83 Million	55,006 Added 24.92%	275,769 $23.5 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $18.8 Million - $21.1 Million	199,861 Added 956.18%	220,763 $21.4 Million
Q2 2018 Aug 10, 2018	SELL	$76.01 - $99.03 $1.28 Million - $1.67 Million	-16,890 Reduced 44.69%	20,902 $1.97 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $112,621 - $134,313	-1,450 Reduced 3.7%	37,792 $3.06 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $1.11 Million - $1.31 Million	13,724 Added 53.78%	39,242 $3.5 Million
Q3 2017 Nov 14, 2017	SELL	$80.6 - $94.95 $58,031 - $68,364	-720 Reduced 2.74%	25,518 $2.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	26,238	26,238 $2.38 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Biomarin Pharmaceutical Inc Transaction History